Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ATXS

Astria Therapeutics (ATXS)

Astria Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATXS
DateTimeSourceHeadlineSymbolCompany
03/11/20254:01PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ATXSAstria Therapeutics Inc
03/11/20258:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
02/28/20259:46AMBusiness WireAstria Therapeutics beginnt Phase-3-Zulassungsstudie ALPHA-ORBIT zu Navenibart bei hereditärem AngioödemNASDAQ:ATXSAstria Therapeutics Inc
02/28/20257:48AMBusiness WireAstria Therapeutics lance l’essai pivot de phase 3 ALPHA-ORBIT du navenibart dans l’œdème angioneurotique héréditaireNASDAQ:ATXSAstria Therapeutics Inc
02/28/20257:33AMBusiness Wireアストリア・セラピューティクス、遺伝性血管性浮腫(HAE)治療向けナベニバートの第3相ピボタル試験ALPHA-ORBITを開始NASDAQ:ATXSAstria Therapeutics Inc
02/27/20258:00AMBusiness WireAstria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary AngioedemaNASDAQ:ATXSAstria Therapeutics Inc
02/25/20258:00AMBusiness WireAstria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care ConferenceNASDAQ:ATXSAstria Therapeutics Inc
02/20/20258:00AMBusiness WireAstria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint CongressNASDAQ:ATXSAstria Therapeutics Inc
02/14/20256:13PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
02/14/20253:45PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
02/04/20254:10PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
02/04/20258:00AMBusiness WireAstria Therapeutics to Present at Upcoming Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:ATXSAstria Therapeutics Inc
02/03/20258:00AMBusiness WireAstria Therapeutics to Present at Upcoming Western Society of Allergy, Asthma & Immunology Annual Scientific SessionNASDAQ:ATXSAstria Therapeutics Inc
01/23/20258:00AMBusiness WireAstria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0310, a Potential Best-in-Class Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic DermatitisNASDAQ:ATXSAstria Therapeutics Inc
01/13/20258:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
01/13/20258:00AMBusiness WireAstria Therapeutics Announces Design of ALPHA-ORBIT Pivotal Phase 3 Trial of Navenibart in HAENASDAQ:ATXSAstria Therapeutics Inc
01/07/20257:45AMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ATXSAstria Therapeutics Inc
01/03/20254:10PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
12/19/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
12/11/20248:00AMBusiness WireAstria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAENASDAQ:ATXSAstria Therapeutics Inc
12/03/20244:10PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
11/14/20245:45PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
11/14/20244:15PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
11/14/202412:03PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ATXSAstria Therapeutics Inc
11/13/20244:21PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
11/13/20244:10PMBusiness WireAstria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:ATXSAstria Therapeutics Inc
11/13/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATXSAstria Therapeutics Inc
11/13/20248:00AMBusiness WireAstria Therapeutics to Present at Upcoming Jefferies London Healthcare ConferenceNASDAQ:ATXSAstria Therapeutics Inc
11/08/20242:17PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ATXSAstria Therapeutics Inc
11/04/20244:10PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ATXS